Anaerobic glycolysis and HIFα expression in haematopoietic stem cells explains its quiescence nature

Journal of Stem Cells

Volumn 10, Issue 2, 2015, Pages 97-106

  Srikanth, Lokanathan ^a   Sunitha, Manne Mudhu ^a   Venkatesh, Katari ^a   Kumar, Pasupuleti Santhosh ^a   Chandrasekhar, Chodimella ^a   Vengamma, Bhuma ^a   Sarma, Potukuchi Venkata Gurunadha Krishna ^a  

^a SRI VENKATESWARA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Anaerobic glycolysis; CD34+ cells; Enzyme activities; Glutaminolysis; HIF1 ; Hypoxic niche

Indexed keywords

CD34 ANTIBODY; CD34 ANTIGEN; GLUCOSE; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; GRANULOCYTE COLONY STIMULATING FACTOR; HYPOXIA INDUCIBLE FACTOR 1ALPHA; HIF1A PROTEIN, HUMAN; OXYGEN;

ANAEROBIC GLYCOLYSIS; APHERESIS; ARTICLE; BONE MARROW; CELL ISOLATION; CELL POPULATION; CELL STRUCTURE; CONTROLLED STUDY; ENZYME ACTIVITY; FLUORESCENCE ACTIVATED CELL SORTING; GIEMSA STAIN; HEMATOPOIETIC STEM CELL; PROTEIN EXPRESSION; SCANNING ELECTRON MICROSCOPY; STEM CELL MOBILIZATION; ANAEROBIC GROWTH; CELL CULTURE; CELL CYCLE G0 PHASE; CELL PROLIFERATION; DRUG EFFECTS; GENETICS; GLYCOLYSIS; HUMAN; METABOLISM; PHYSIOLOGY;

ANAEROBIOSIS; ANTIGENS, CD34; CELL PROLIFERATION; CELLS, CULTURED; G0 PHASE; GLUCOSE; GLYCOLYSIS; HEMATOPOIETIC STEM CELLS; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; OXYGEN;

EID: 84959361924     PISSN: 15568539     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Lemischka I.A few thoughts about the plasticity of stem cells. Exp. Hemato, 2002, 30, 848–852.
2. Verfaillie CM. Adult stem cells: assessing the case for pluripotency. Trends Cell Biol, 2002, 12, 502–508.
3. Wagers AJ, Weissman IL.Plasticity of adult stem cells. Cell, 2004, 116, 639–648.
4. Sauer H, Wartenberg M, Hescheler J. Reactive oxygen species as intracellular messengers during cell growth and differentiation. Cell. Physiol. Biochem, 2001, 11, 173–186.
5. Droge W. Free radicals in the physiological control of cell function. Physiol. Rev, 2002, 82, 47–95.
6. Finkel T. Oxidant signals and oxidative stress. Curr. Opin. Cell Biol, 2003, 15, 247–254.
7. Busuttil RA, Rubio M, Dolle MET, Campisi J, Vijg J. Oxygen accelerates the accumulation of mutations during the senescence and immortalization of murine cells in culture. Aging Cell, 2003, 2, 287–294.
8. Cipolleschi MG, Dello Sbarba P, Olivotto M. The role of hypoxia in the maintenance of hematopoietic stem cells. Blood, 1993, 82, 2031–2037.
9. Eliasson P, Jonsson JI. The hematopoietic stem cell niche: low in oxygen but a nice place to be. J. Cell. Physiol, 2010, 222, 17–22.
10. Lekli I, Gurusamy N, Ray D, Tosaki A, Das DK. Redox regulation of stem cell mobilization. Can. J. Physiol. Pharmacol, 2009, 87, 989–995.
11. Koshiji M, Kageyama Y, Pete EA, Horikawa I, Barrett JC, Huang LE. HIF-1alpha induces cell cycle arrest by functionally counteracting Myc. EMBO J, 2004, 23, 1949–1956.
12. Takubo K, Goda N, Yamada W, Iriuchishima H, Ikeda E, Kubota Y, Shima H, Johnson RS, Hirao A, Suematsu M, Suda T. Regulation of the HIF-1alpha level is essential for hematopoietic stem cells. Cell Stem Cell, 2010, 7(3), 391-402.
13. Wang GL, Jiang BH, Rue EA, Semenza GL. Hypoxiainducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension. Proc. Natl. Acad. Sci. USA, 1995, 92, 5510–5514.
14. Ivan M, Haberberger T, Gervasi DC, Michelson KS, Gunzler V, Kondo K, Yang H et al. Biochemical purification and pharmacological inhibition of a mammalian prolyl hydroxylase acting on hypoxiainducible factor. Proc. Natl. Acad. Sci. USA, 2002, 99, 13459–13464.
15. Simsek T, Kocabas F, Zheng J, Deberardinis RJ, Mahmoud AI, Olson EN, Schneider JW, Zhang CC, Sadek HA. The distinct metabolic profile of hematopoietic stem cells reflects their location in a hypoxic niche. Cell Stem Cell, 2010, 7, 380–390.
16. Takubo K, Nagamatsu G, Kobayashi CI, Nakamura-Ishizu A, Kobayashi H, Ikeda E, Goda N, et al. Regulation of glycolysis by Pdk functions as a metabolic checkpoint for cell cycle quiescence in hematopoietic stem cells. Cell Stem Cell, 2013, 12, 49–61.
17. Wise DR, Thompson CB. Glutamine addiction: a new therapeutic target in cancer. Trends Biochem. Sci, 2010, 35, 427–433.
18. Son J, Lyssiotis CA, Ying H, Wang X, Hua S, Ligorio M, Perera RM et al. Glutamine supports pancreatic cancer growth through a KRAS-regulated metabolic pathway. Nature, 2013,496, 101–105.
19. Newsholme EA, Crabtree B, Ardawi MS. The role of high rates of glycolysis and glutamine utilization in rapidly dividing cells. Biosci. Rep, 1985, 5, 393–400.
20. Sarma PV, Subramanyam G. In vitro cardiogenesis can be initiated in human CD34+ cells. Indian Heart J, 2008, 60, 95–100.
21. Sutherland DR, Anderson L, Keeney M, Nayar R, ChinYee I. The ISHAGE guidelines for CD34+ cell determination by flow cytometry. International Society of Hematotherapy and Graft Engineering. J Hematother. 1996, 5,213-226.
22. Mahe B, Menard A, Accard F, Pineau D, Robillard N, Hermouet S. In vitro expansion of CD34+ cells from peripheral blood of myeloma and lymphoma patients. Nouv Rev Fr Hematol, 1995,37,335-341.
23. Livak KJ, Schmittgen TD.Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods, 2001, 25, 402–408.
24. Nielsen JS, McNagny KM. Novel functions of the CD34 family. J. Cell Sci, 2008, 121, 3683–3692.
25. Piccoli C, Agriesti F, Scrima R, Falzetti F, Di Ianni M, Capitanio N.To breathe or not to breathe: the haematopoietic stem/progenitor cells dilemma. Br. J. Pharmacol, 2013,169, 1652–1671.
26. Ito K, Suda T. Metabolic requirements for the maintenance of self-renewing stem cells. Nat. Rev. Mol. Cell Biol, 2014, 15, 243–256.
27. Ardawi MS, Newsholme EA. Glutamine metabolism in lymphocytes of the rat. Biochem. J, 1983, 212, 835–842.